Abstract Neuroimmune processes contribute to hypoxicischemic damage in the immature brain and may play a role in the progression of particular variants of neonatal encephalopathy. The present study was designed to elucidate molecular mediators of interactions between astrocytes, neurons, and infiltrating peripheral immune cells after experimental neonatal hypoxia-ischemia (HI). Splenectomy was performed on postnatal day 7 Sprague-Dawley rats 3 days prior to HI surgery, in which the right common carotid artery was permanently ligated followed by 2 h of hypoxia (8 % O 2 ). Quantitative analysis showed that natural killer (NK) and T cell expression was reduced in spleen but increased in the brain following HI. Elevations in cyclooxygenase-2 (COX-2) expression after HI by immune cells promoted interleukin-15 (IL-15) expression in astrocytes and infiltration of inflammatory cells to site of injury; additionally, these downregulated the prosurvival protein, phosphoinositide-3-kinase (PI3K), resulting in caspase 3-mediated neuronal death. The removal of the largest pool of peripheral immune cells in the body by splenectomy and COX-2 inhibitors as well as rendering NK cells inactive by CD161 knockdown significantly ameliorated cerebral infarct volume at 72 h, diminished body weight loss and brain and systemic organ atrophy, and reduced neurobehavioral deficits at 3 weeks. Herein, we demonstrate with the use of surgical approach (splenectomy) and with pharmacological loss-gain function approach using COX-2 inhibitors/agonists as well as with NK cell-type-specific siRNA that after neonatal HI, the infiltrating peripheral immune cells may modulate downstream targets of cell death and neuroinflammation by COX-2-regulated signals.
Introduction
The inflammatory response, which is characterized by recruitment of circulating immune cells after their deployment from peripheral lymphatic organs, has been implicated as a core component of damage to the immature brain following neonatal hypoxia-ischemia (HI) [1] . Although many therapeutic interventions have been explored to prevent and/or mitigate the inflammatory sequelae of perinatal HI, few such interventions have proven clinically viable. One explanation has been that the immunoinflammatory response is multifaceted, in that activation of immune cells may have both detrimental and neuroprotective effects [2] . Increasing evidence suggests that a more integrative approach to therapy may resolve this paradox [3, 4] . In theory, redirecting our attention from neuron-driven outcomes toward the molecular mediators believed to orchestrate interactions between brain and immune cells may prove a more fruitful investigative approach in neonatal HI [5] .
Cyclooxygenase-2 (COX-2), a well-established contributor to ischemic brain injury, might serve as a prime candidate for such a molecular-mediated investigation [6, 7] . In particular, COX-2 may mediate the mechanism by which activated immune cells induce proinflammatory cytokine production by astrocytes [8] . Recent data suggests that among these cytokines, the enhanced interleukin-15 (IL-15) expression in astrocytes is a major propagator of inflammatory responses after central nervous system injury [9] . Yet it still remains to be determined whether astrocytes respond to COX-2 effectors from infiltrating immune cells by producing IL-15, which then further orchestrates the inflammatory response and/or cell death in the immature brain.
Additionally, the degree of involvement from the innate immune system correlates with the extent of neuronal damage in the postischemic tissue [2] . Studies suggest dysfunction of the phosphoinositide-3-kinase (PI3K)/Akt survival pathway in triggering apoptotic cascades by inflammatory cells in the brain [10] . However, it is unknown whether downregulation of the PI3K pathway and subsequent neuronal death in HI-injured rats occur in response to COX-2 activation in infiltrating immune cells.
From the ischemic stroke model comes an indication that progression of brain injury can be mediated by immune cells originating in the spleen [11] . We hypothesized that neurological outcomes in stroked neonatal rats can be ameliorated by targeting splenic immune cells and their modulatory functions mediated by COX-2. To elucidate the possible impact of the peripheral immune cells on astroglia-neuron interactions, we removed the spleen, the largest pool of peripheral immune cells prior to HI and studied neuronal and astrocytic inflammatory pathways followed by the evaluation of short-and long-term outcomes in the neonatal rats. We also used a gain and loss of function approach (pharmacological activation or inhibition, respectively) for COX-2, a neutralizing antibody for IL-15, and a gene silencer for natural killer (NK) cells in both splenectomized and nonsplenectomized rats to verify the role of COX-2 in splenic immune cell responses following HI. Here, we identify infiltrating splenic immune cells as a major source of enhanced COX-2 expression in the ischemic brain and implicate COX-2 for causation of signaling pathways in astrocytes and neurons that lead to a worsened outcome.
Methods

Surgical Procedures
The protocol detailing this study was approved by the Institutional Animal Care and Use Committee at Loma Linda University. Splenectomy, on postnatal day 7 pups, entailed a skin incision at the upper left quadrant of the abdomen, exteriorization of the spleen through the incision, and cauterization of the blood vessels. Unsplenectomized groups had the abdominal cavity opened, the spleen isolated and then reclosed. Postnatal day 10 pups were placed on a surgical table maintained at 37°C and anesthetized by inhalation with 3 % isoflurane. Briefly, HI surgery entailed permanent ligation of the right common carotid artery, followed by 1.5 h of recovery and then placement in a glass jar perfused for 2 h with 8 % oxygen [7] . Rats were sacrificed under general anesthesia by decapitation at 3 h, 3 days, or 3 weeks post-HI.
Pharmacological Manipulation
Some postnatal day 9 pups were treated intraperitoneally with 30 mg/kg COX-2 inhibitor (NS398; Cayman Chemical) or intraventricularly with 0.01 mg/kg COX-2 agonist, 4-hydroxynonenal (4-HNE; Cayman Chemical), or with 1 μl NK cell (CD161) siRNA. Others were treated intraventricularly with 1.5 μl IL-15 neutralizing antibody (Santa Cruz Biotechnology, Inc.) 1 h pre-HI.
Measurement of Infarct Size
Brain tissue was collected after transcardial perfusion with 0.1 mol/L phosphate-buffered saline, cut at 2-mm intervals into five coronal sections, and incubated in 2 % 2,3,5-triphenyltetrazolium chloride (TTC) for infarct volume measurement [12] .
Evaluation of Organ Damage
Cerebral hemispheres (separated by a midline incision) of animals and spleen of unsplenectomized animals were isolated and then weighed on a high-precision balance (sensitivity±0.001 g).
Neurological Assessment
Rats were placed onto an elevated wire grid floor (36×13 in.) for 2 min; foot faults were noted when a complete paw fell through the bars for assessment of motor coordination [13] . Rats were placed in the stem of the T-maze and allowed to explore until an arm of the maze was chosen, as an assessment of short-term or working memory [14] . The sequence of left and right arm choices over 10 trials was expressed as the rate of spontaneous alternation. For the following tests, rats were given a score of 100 for immediate and correct placement, 50 for delayed and/or incomplete placement, or 0 for no placement: postural reflex, proprioceptive limb placing, lateral pressure towards edge, and lateral limb placing [7] .
Immunofluorescence Analysis
The following antibodies were used: CD161 (1:100; Serotec Co.), CD3 (1:100; Serotec Co.), COX-2 (1:100; Santa Cruz Biotechnology, Inc.), IL-15 (1:100; Santa Cruz Biotechnolgy, Inc.), GFAP (1:100; Millipore), cleaved caspase 3 (1:100; Cell Signaling), NeuN (1:100; Millipore), Iba1 (1:100; Wako Chemicals), CD68 (1:100; Millipore), or myeloperoxidase (MPO) (1:100; Dako) on 10-μm frozen sections of tissue collected 3 days post-HI. The absolute number of positive cells per square millimeter was counted in three peri-infarct regions of the ipsilateral cerebral cortex or in three marginal zone areas immediately adjacent to the white pulp of the spleen [7] .
Western Blot Analysis
Homogenates of ipsilateral cerebral hemispheres were processed (Fathali et al., 2010) for analysis using antibodies against: COX-2 (1:300), CD161 (1:200), CD3 (1:200), PI3K (1:300; Santa Cruz Biotechnology, Inc.), procaspase 3 (1:1,000; Cell Signaling), cleaved caspase 3 (1:1,000), or beta actin (1:1,000, Santa Cruz Biotechnology). Optical density was determined using NIH Image J software and expressed relative to beta actin.
RT-PCR Analysis of NK Cells
Total RNA was isolated from the ipsilateral hemisphere with TRIzol reagent and cDNA prepared using SuperScript FirstStrand Synthesis System for RT-PCR (Invitrogen) [15] . PCR amplification used primers from Invitrogen (see below for sequence) and was done by means of thermocycler (iCycler; Bio-Rad Laboratories). PCR products were electrophoresed in 2 % agarose gel in Tris-borate-Ethylenediaminetetraacetic acid (EDTA) buffer. Densities of bands were determined by BioRad Quantity One software, and were expressed relative to GAPDH bands.
Klrb1b (CD161) [16] :
Forward: 5′-GTTCTAGACTCGGCTGTGCTTGCCT-3′ Reverse: 5′-CTGAATTCTGGTAAAGTAATCGAG GTACG-3′
GAPDH [15] :
Forward: 5′-ACCACAGTCCATGCCATCAC-3′ Reverse: 5′-TCCACCACCCTGTTGCTGTA-3′.
Assessment of Cell Death
Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) method was done with a kit (Roche Applied Science). Sections were mounted with antifade mounting medium (Molecular Probes) under glass cover slips.
Data Analysis
Observers were blind to the actual animal groupings. Results were expressed as mean ± SEM. One-way analysis of variance (ANOVA) Holm-Sidak correction or the unpaired Student's t test (when only two groups were available for comparison) were used to determine significance in differences between means. Kruskal-Wallis ANOVA followed by Dunn's test was used for neurobehavioral analysis. P<0.05 was taken as significant.
Results
Splenectomy Attenuates HI-induced Cerebral Infarction
To detect whether spleen-derived immune cells contribute to cerebral infarction, we quantified primary (3 h post-HI) and secondary (3 days post-HI) infarct volume of splenectomized and unsplenectomized rats (Fig. 1a) . Removal of the spleen prior to HI had no effect on primary infarct (6.19±1.11 versus 6.50±0.77) but significantly reduced secondary infarct (10.45±2.94 versus 35.93±1.69). These findings suggest that splenic cells mediate the progression of cerebral infarction having no effect on the initial extent of brain injury.
Splenectomy Attenuates HI-induced Extended Brain Damage
In order to determine the role of the spleen in long-term HIrelated brain damage, we used reductions in spleen size and hemispheric weight as parameters [17, 18] . HI-injured rats had significant spleen ( Splenectomy Improves Short-and Long-term Body Weight Gain after HI Body weight gain post-HI is an indicator of general wellbeing [19] . Accordingly, we found HI-injured rats with intact spleen gained less weight during the acute phase as compared to their splenectomized counterparts (Fig. 1d) . Next, weekly body weights were taken to determine if these somatic differences had lasting effects (Fig. 1e ). HI rats with intact spleen were unable to catch up to the weight of sham rats for the entirety of the study; while prior splenectomy maintained the weight of the animals within control limits at all weekly time intervals.
Splenectomy Improves HI-induced Neurological Behavior Deficits
Lifetime consequences of perinatal HI may include motor, cognitive, and behavioral deficits [20] . Several functional tests were used to evaluate the spleen's role on long-term neurological behavior (Fig. 1f) 
Cerebral Ischemia Alters Expression of Immune Cells in Spleen and Brain
Lymphocytes are major inflammatory effectors of damage after cerebral ischemia [21, 22] . However, the contributions of peripheral immune cells to the ischemic neonatal brain are unclear, and due to vast differences in immune response between neonates and adults, much of the insight obtained from adult studies cannot be inferred to be the same in the immature brain [23, 24] . Accordingly, we sought to determine the leukocyte subsets possibly released by the spleen (Fig. 2a-c) 
COX-2 is a major effecter of ischemic cerebral injury [6, 7] . Therefore, we sought to determine the contribution of the spleen on COX-2 expression in the HI-injured brain 3 days postinsult (Fig. 3a) . Results showed that COX-2 expression was elevated in HI rats with intact spleen but significantly suppressed by prior splenectomy. To verify the efficacy of the inhibitor (NS398) and agonist (4-HNE) used in our experimental studies for suppressing and upregulating COX-2, respectively, the pharmacological agents were administered to HI-induced rats with or without a spleen.
NS398 given to HI rats with intact spleen significantly reduced COX-2 density compared to their untreated counterpart, but there was no significant difference in COX-2 density between NS398-treated or NS398-untreated HI rats with prior splenectomy. 4-HNE significantly enhanced COX-2 expression in HI-injured groups, although less so in splenectomized rats.
COX-2 May Contribute to HI-induced Body Weight Reduction
To elucidate whether the low body weights of HI rats with intact spleen were COX-2-mediated, rats were administered NS398 or 4-HNE on postnatal day 9 followed 1 day later by sham or HI surgery. We found NS398 maintained body weights after HI (Fig. 3b, left side) , while 4-HNE groups showed a trend for lower body weights (Fig. 3b, right side) .
COX-2 Colocalizes with Immune Cell Subsets After HI
To determine whether the immune cell subsets infiltrating the ischemic brain 3 days postinsult expressed COX-2, double immunofluorescence was performed (Fig. 3c, d) (Fig. 3e) and further Western blot analysis demonstrated equalization of COX-2 levels between nonischemic groups and ischemic group with CD161 knockdown (Fig. 3f) .
COX-2 May Promote IL-15 Expression by Astrocytes
By-products of reactive astrocytes play a key role in regulating the extent of the immune response [25] . Therefore, we sought to elucidate whether peripheral immune cells propagate the neuroinflammatory response by inducing expression of the proinflammatory cytokine IL-15 in astrocytes 3 days post-HI (Fig. 4a, b) . Ischemic cortical areas of rats with intact spleen revealed elevated IL-15-immunoreactive astrocytes but a marked reduction in splenectomized animals. Next, we verified whether these differences were COX-2 mediated and found suppressed IL-15 immunoreactivity in NS398-treated HI animals. While 4-HNE enhanced IL-15-expressing astrocytes, colocalization was substantially less in HI rats with prior splenectomy. To determine the role of IL-15 in HI-induced damage, we evaluated infarct volume 3 days post-HI and body weights of rats after administration of IL-15-neutralizing antibody and found significant improvements in both parameters (Fig. 4c, d ).
COX-2 May Mediate the Local Inflammatory Response
Microglia, macrophage, and neutrophil numbers in the ischemic hemisphere are greatest 3 days poststroke [2] . We found HI-induced rats with intact spleen showed elevated expression of these inflammatory cells 3 days post-HI, while prior splenectomy suppressed this outcome (Fig. 5a, b) . NS398 to HI-injured rats with intact spleen also reduced inflammatory cell abundance. On the other hand, 4-HNE significantly increased neuroinflammation, although in splenectomized rats, there were still less activated microglia and macrophages.
COX-2 May Promote Cell Death Pathway
To determine whether infiltrating immune cells exert detrimental effects by downregulating specific prosurvival cellular signals, the expression of PI3K was measured at the 3-day time point and found to be significantly reduced in HIinjured animals with intact spleen compared to those with prior splenectomy (Fig. 6a) . NK cells may be responsible for these differences as PI3K levels were equal between groups after CD161 siRNA administration. Next, we determined whether IL-15 regulates PI3K expression and found that IL-15 inhibition normalized PI3K levels for HI rats with intact spleen. To, then, investigate the molecular mechanism by which decreased PI3K may have an apoptotic effect, we quantified cleaved and procaspase 3 levels at 3 days post-HI. We found HI-induced rats with splenectomy had lower levels of the cleaved caspase 3 and higher levels of inactive procaspase 3 compared to those with intact spleen (Fig. 6b) . Moreover, we found that NS398 to HI rats with intact spleen decreased expression of activated caspase 3, while the reverse was shown with 4-HNE.
Splenectomy Attenuates Caspase-mediated Neuronal Death
An immunofluorescent study was done to examine whether neuronal cells were involved in caspase-mediated pathways induced by infiltrating immune cells. We found elevated cleaved caspase 3-expressing neurons in HI rats with intact spleen compared to splenectomized rats at 3 days post-HI (Fig. 6c, d ). TUNEL analysis was done to determine whether the effects on cell death were limited to neurons (Fig. 6e) . Results showed that HI rats with intact spleen abundantly expressed TUNEL-positive cells localized in the nucleus of neuronal cells and not astrocytes, thereby further supporting our proposed mechanism for astrocyte-neuron dynamics in response to immune cells after HI (Fig. 6f) .
Discussion
All components of the neurovascular unit respond to inflammation; therefore, interventions aimed at preserving merely neurons have proven not to be clinically effective. Therefore, it is crucial to understand how cell components within the unit interact with each other during inflammatory responses. In this study, we characterize the mechanistic interaction between cell of the glial and neuronal compartments in response to immigrating peripheral immune cells after a hypoxic-ischemic insult in the neonatal rat. Our major new finding is that the magnitude of inflammatory response in the ischemic immature brain is proportional to the extent of peripheral immune cell invasion and that these cells employ COX-2 to modulate astrocyte-neuron signaling and the extent of injury including infarct growth, long-term brain atrophy, somatic restriction, and functional deterioration.
We evidenced marked reductions in infarct volume in HIinjured animals with prior splenectomy as compared to animals with an intact spleen. Since the operative variable was splenectomy, our data, in a compelling way, links progression of brain injury post-HI to splenic-immune cell populations. Previous reports indicated that inflammatory responses are a core component in the sequelae of neonatal HI, comprising a significant portion of secondary brain injury [26] .
More specifically, we have found that the influx of COX-2-expressing immune cells enhances astrocytic IL-15 production and caspase 3-mediated neuronal death, which, in sum, may propagate brain damage. Our study has first revealed that splenic cells appear to be a crucial source of COX-2 as splenectomy dramatically reduced COX-2 expression in the ischemic brain. Of the many spleen-derived immune cells that may be involved in COX-2 production, we focused on NK cells that are a component of the innate immune system. Our findings suggest a substantial involvement of NK cells in the production of COX-2 after HI; however, to further verify this, a gene silencer against NK cells was administered. Results demonstrated that knocking In line with evidence implicating astrocyte-derived IL-15 in microglial activation, we observed an increase in IL-15 expression by astrocytes as well as increases in neutrophil and macrophage abundance and microglia activation in brain-injured animals [9, 27, 28] . On the other hand, splenic removal prior to HI insult markedly attenuated these associated changes. Moreover, pharmacological blockade of COX-2 afforded a tremendous reduction in IL-15-mediated inflammatory propagation, as did splenectomy in the HI-injured rats. This led us to believe that downstream COX-2 effectors from splenic immune cells may be potent stimulators of IL-15 production by binding to E-prostanoid receptors, which are present on astrocytes [29] . These COX-2-regulated signaling patterns were further supported when opposite effects (enhanced IL-15 and inflammatory propagation) were seen in HI-injured rats with administration of 4-HNE, a COX-2 agonist [30, 31] .
Although other lymphocyte-exclusive by-products, such as IL-2, have also been shown to stimulate IL-15 production, experimental studies using IL-2-deficient mice have reported no changes in immune function [32, 33] . Previous studies also showed that IL-15 plays a major role in inflammatory cell chemoattraction and stimulation of killer activity in NK cells [34, 35] . Concordantly, our study shows that COX-2 blockade, which results in reduced IL-15 brain expression, decreases infiltration of inflammatory cells. However, COX-2-dependent expression of IL-15 is important not only for regulation of neuroinflammation but also for neuronal death through the downregulation of PI3K/Akt pathway [9] when chronically elevated. Consequently, we found that inhibition of IL-15 in the ischemic brain led to increased levels of PI3K. Likewise, a reduction in COX-2-expressing NK cells correlated to increased PI3K levels and decreased cleaved caspase 3 expression in neurons. Furthermore, the HI-induced elevations in cell death appear to be neuron-limited and not include astrocytes. Studies by earlier authors have shown that coculture studies incubated with COX inhibitors suppress glialmediated paracrine damage to neurons [29] . Collectively, this supports our notion that astrocytes are actively participating in production of downstream effectors that induce neurodegeneration. However, future studies are needed to determine the exact mechanism of COX-2-mediated increases in cell death proteins after HI, involving IL-15 binding to the IL-15/PI3K neuronal complex [32] .
In the present study, we reveal that the HI-induced neuronal apoptosis [36] and activation of local inflammation [37] may be triggered by spleen-derived NK cells. Depletion of splenic immune cells through splenectomy led to neuroprotection and a lasting and robust improvement across most neurobehavioral tasks. However, it cannot be ruled out that the splenectomy-induced neuroprotection afforded 3 weeks post-HI may, in fact, not be a direct effect of there being less COX-2 producing immune cells to infiltrate the ischemic brain in the acute stage of HI. At later stages, studies have shown that adaptive immune responses promote production of neurotrophic factors involved in remodeling the postischemic brain [38] . Therefore, a possible explanation for the long-term benefits in our study could be that immunologic cells involved in enhancing brain plasticity within weeks after HI may have migrated from other lymphoid organs in the absence of the spleen [39] . Most importantly, this amelioration of long-term outcomes provides the basis for the clinical relevance of this study. Additionally, despite an inclusion of sham-operated controls, the surgery, by itself, was more extensive in splenectomized rats in this present study, as removal of the spleen was not replicated in the sham-operated rats. Thus, in theory, surgical intervention on spleen tissue/vasculature might alter inflammatory responses and produce effects unrelated to splenic cell ablation thereby affecting outcomes measured at 3 days after surgery. However, it may appear that only cutting through body envelopes and muscles can produce a severe inflammatory reaction, while surgical trauma due to spleen dissection alone may not be significant. Laparoscopic surgery studies have shown a reduced inflammatory response as compared to conventional open surgery [40] . Moreover, our earlier study with splenic irradiation that eliminated splenic cells without splenectomy showed robust benefits in terms of reducing brain invasion by immune cells after cerebral ischemia [41] . Therefore, present experiments, by including sham-operated controls that underwent opening of abdominal wall similar to splenectomized animals, appear adequately guarded against factors confounding inflammatory response in the treatment group. In summary, we have identified a previously unrecognized COX-2-dependent link between splenic immune cells and signaling pathways controlling cellular inflammatory targets and neuronal death after neonatal HI. We also confirmed that the spleen appears to be a major source of peripheral immunologic cells that infiltrate and exacerbate brain damage through their interactions with astrocytes and neurons. Consequently, a depletion of splenic cells offers lasting protection against HI-induced neonatal brain injury. There is conformity between our present study and the previous work showing that both splenectomy and angiotensin-converting-enzyme (ACE) inhibitor can reduce monocyte infiltration in myocardium and improve healing process after ischemia [42] . Therefore, we believe that new modalities and pharmacological agents capable of reducing deployment of immunological cells from spleen offer therapeutic potential for the treatment of cerebrovascular and cardiovascular injuries.
